METHYLPREDNISOLONE ACETATE

METHYLPREDNISOLONE ACETATE was reported 8122 times

METHYLPREDNISOLONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 68 0.7816
1 NEUROLOGIC NEGLECT SYNDROME 152 0.2734
2 MIDDLE LOBE SYNDROME 8 0.2105
3 TEMPERATURE REGULATION DISORDER 407 0.1825
4 CAROTID ARTERY THROMBOSIS 152 0.1790
5 HEPATIC ENZYME 24 0.1611
6 TENOSYNOVITIS STENOSANS 79 0.1418
7 ADJUSTMENT DISORDER 146 0.1123
8 THYROID ATROPHY 10 0.1064
9 MENINGITIS FUNGAL 22 0.0936
10 ARACHNOIDITIS 63 0.0910
11 ALLERGY TO CHEMICALS 105 0.0843
12 POST CHOLECYSTECTOMY SYNDROME 23 0.0813
13 RHEUMATOID FACTOR 8 0.0741
14 SYNOVIAL DISORDER 31 0.0681
15 FOOD ALLERGY 494 0.0639
16 RHEUMATOID LUNG 60 0.0628
17 RED BLOOD CELL SEDIMENTATION RATE DECREASED 16 0.0613
18 PERSONALITY DISORDER 153 0.0584
19 TENOSYNOVITIS 159 0.0576
20 FACET JOINT SYNDROME 187 0.0574
21 GRANULOCYTE COUNT INCREASED 23 0.0568
22 LYMPHOID TISSUE HYPOPLASIA 8 0.0523
23 RHEUMATOID NODULE 139 0.0504
24 MENINGITIS CHEMICAL 11 0.0500
25 SCLERITIS 78 0.0487
26 CREPITATIONS 145 0.0486
27 BLOOD FOLATE DECREASED 35 0.0481
28 BURSITIS 566 0.0466
29 THYMUS HYPOPLASIA 8 0.0460
30 FOETAL DEATH 237 0.0457
31 COELIAC DISEASE 422 0.0430
32 C-REACTIVE PROTEIN DECREASED 28 0.0429
33 BLOOD IMMUNOGLOBULIN A INCREASED 23 0.0427
34 SYNOVIAL CYST 196 0.0424
35 HUMAN BOCAVIRUS INFECTION 8 0.0423
36 ASPARTATE AMINOTRANSFERASE 10 0.0410
37 CRYSTAL ARTHROPATHY 8 0.0381
38 IMMUNODEFICIENCY 521 0.0349
39 VITAMIN B12 INCREASED 25 0.0314
40 HEPATIC ENZYME DECREASED 14 0.0312
41 ONYCHOMADESIS 129 0.0307
42 GANGRENE 182 0.0302
43 PLEURITIC PAIN 83 0.0300
44 GLOMERULAR FILTRATION RATE INCREASED 24 0.0291
45 DACTYLITIS 26 0.0265
46 INFECTIVE EXACERBATION OF BRONCHIECTASIS 8 0.0261
47 ELECTRIC SHOCK 22 0.0257
48 NOROVIRUS TEST POSITIVE 8 0.0246
49 CUSHINGOID 78 0.0243
50 CYSTITIS BACTERIAL 8 0.0237
51 ANTINUCLEAR ANTIBODY POSITIVE 76 0.0234
52 ARTERIAL OCCLUSIVE DISEASE 183 0.0233
53 SENSORY LOSS 185 0.0230
54 PULMONARY TOXICITY 162 0.0229
55 HYPOCHOLESTEROLAEMIA 8 0.0227
56 JOINT RANGE OF MOTION DECREASED 302 0.0225
57 SPINAL STENOSIS 90 0.0218
58 ONYCHOMYCOSIS 95 0.0216
59 RHEUMATOID FACTOR INCREASED 24 0.0215
60 MENINGITIS TUBERCULOUS 12 0.0215
61 JOINT EFFUSION 142 0.0206
62 DUODENAL ULCER PERFORATION 149 0.0200
63 URINE LEUKOCYTE ESTERASE POSITIVE 14 0.0200
64 HEMIPLEGIA 162 0.0195
65 EXTRADURAL ABSCESS 15 0.0191
66 PRESCRIBED OVERDOSE 366 0.0189
67 PERIPHERAL VENOUS DISEASE 77 0.0188
68 FINGER DEFORMITY 91 0.0188
69 BLEPHAROSPASM 117 0.0186
70 HAND DEFORMITY 243 0.0185
71 ROTATOR CUFF REPAIR 32 0.0183
72 CONTRAINDICATED PRODUCT ADMINISTERED 552 0.0182
73 BREAST CANCER STAGE III 118 0.0182
74 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 130 0.0181
75 RHEUMATIC FEVER 80 0.0179
76 SUSPECTED PRODUCT CONTAMINATION 18 0.0178
77 GRIP STRENGTH DECREASED 156 0.0177
78 ARTHRITIS BACTERIAL 71 0.0173
79 TENDERNESS 177 0.0170
80 C-REACTIVE PROTEIN ABNORMAL 104 0.0162
81 FIBROMYALGIA 392 0.0161
82 AFFECT LABILITY 155 0.0161
83 CUTANEOUS SYMPTOM 11 0.0161
84 MOTOR DYSFUNCTION 164 0.0161
85 INTERVERTEBRAL DISCITIS 30 0.0159
86 ASPARTATE AMINOTRANSFERASE ABNORMAL 24 0.0157
87 FOLLICULITIS 164 0.0156
88 PRODUCT LABEL CONFUSION 90 0.0154
89 SYNOVITIS 277 0.0153
90 JOINT NOISE 30 0.0153
91 SACROILIITIS 27 0.0143
92 C-REACTIVE PROTEIN 13 0.0140
93 SECONDARY IMMUNODEFICIENCY 17 0.0140
94 MUSCLE INJURY 114 0.0137
95 ALANINE AMINOTRANSFERASE ABNORMAL 29 0.0137
96 UPPER RESPIRATORY TRACT INFECTION 635 0.0137
97 INJECTION SITE INFECTION 45 0.0137
98 VIRAL UPPER RESPIRATORY TRACT INFECTION 64 0.0135
99 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 31 0.0134
100 COORDINATION ABNORMAL 187 0.0134
101 MUSCLE SPASTICITY 160 0.0130
102 ENTHESOPATHY 20 0.0128
103 SINUS CONGESTION 171 0.0126
104 INJECTION SITE ABSCESS 31 0.0124
105 MYCOBACTERIUM CHELONAE INFECTION 9 0.0122
106 HYPERCHOLESTEROLAEMIA 117 0.0121
107 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 15 0.0120
108 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 8 0.0120
109 DEFORMITY 111 0.0119
110 PLEURAL FIBROSIS 12 0.0118
111 BACK INJURY 127 0.0117
112 LIP DRY 105 0.0115
113 RHEUMATOID ARTHRITIS 1294 0.0114
114 MYOFASCIAL PAIN SYNDROME 8 0.0113
115 SKIN HAEMORRHAGE 165 0.0111
116 HELICOBACTER INFECTION 113 0.0110
117 VERTEBRAL FORAMINAL STENOSIS 9 0.0109
118 PRODUCT CONTAMINATION MICROBIAL 13 0.0109
119 WHITE BLOOD CELLS URINE POSITIVE 20 0.0106
120 ATELECTASIS 102 0.0105
121 PEMPHIGUS 131 0.0105
122 PARAPLEGIA 30 0.0104
123 ENTEROCOCCAL BACTERAEMIA 11 0.0104
124 PSEUDOMONAL SEPSIS 18 0.0103
125 RASH ERYTHEMATOUS 491 0.0103
126 RESPIRATORY TRACT CONGESTION 158 0.0099
127 ARTHRITIS INFECTIVE 46 0.0099
128 SPINAL CORD INJURY 17 0.0097
129 NAIL DISORDER 85 0.0097
130 HEMIPARESIS 164 0.0097
131 PRODUCT CONTAMINATION 34 0.0095
132 LUPUS VULGARIS 12 0.0095
133 HUMAN HERPESVIRUS 6 INFECTION 18 0.0095
134 HEPATIC ENZYME INCREASED 630 0.0092
135 WOUND INFECTION 101 0.0092
136 CHORIORETINOPATHY 13 0.0091
137 CAUDA EQUINA SYNDROME 7 0.0091
138 FLANK PAIN 85 0.0091
139 OSTEOSCLEROSIS 14 0.0089
140 BONE DENSITY ABNORMAL 33 0.0088
141 SINUS DISORDER 174 0.0088
142 VITAMIN B12 DEFICIENCY 35 0.0086
143 FLUID RETENTION 430 0.0084
144 LIPOATROPHY 8 0.0084
145 ADRENAL SUPPRESSION 7 0.0083
146 PERICARDITIS 139 0.0083
147 BONE EROSION 29 0.0082
148 JOINT SWELLING 967 0.0080
149 LIVE BIRTH 67 0.0080
150 FEBRILE BONE MARROW APLASIA 34 0.0080
151 VITAMIN D DEFICIENCY 78 0.0080
152 CORTISOL DECREASED 9 0.0079
153 C-REACTIVE PROTEIN INCREASED 284 0.0078
154 INFUSION RELATED REACTION 512 0.0077
155 EAR PRURITUS 27 0.0077
156 SNEEZING 171 0.0076
157 MENINGITIS 49 0.0073
158 TREATMENT FAILURE 607 0.0073
159 DRUG INTOLERANCE 703 0.0073
160 BONE SWELLING 7 0.0072
161 EATING DISORDER 154 0.0072
162 ANGINA PECTORIS 206 0.0072
163 JOINT INSTABILITY 10 0.0071
164 RASH MACULO-PAPULAR 158 0.0071
165 BENIGN NEOPLASM 8 0.0071
166 SUSPECTED OFF LABEL USE 32 0.0071
167 OSTEOARTHRITIS 300 0.0071
168 ATYPICAL MYCOBACTERIAL INFECTION 10 0.0071
169 DEEP VEIN THROMBOSIS POSTOPERATIVE 14 0.0070
170 MENINGITIS BACTERIAL 10 0.0070
171 IATROGENIC INJURY 9 0.0070
172 PORPHYRIA ACUTE 10 0.0070
173 EXPOSURE DURING PREGNANCY 431 0.0069
174 DECREASED IMMUNE RESPONSIVENESS 67 0.0068
175 QUADRIPLEGIA 14 0.0068
176 ULCER 107 0.0067
177 X-RAY ABNORMAL 12 0.0067
178 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 15 0.0067
179 WOUND 184 0.0066
180 DISLOCATION OF VERTEBRA 15 0.0066
181 JOINT CREPITATION 13 0.0065
182 ENTEROBACTER INFECTION 11 0.0065
183 NORMAL NEWBORN 35 0.0064
184 NODULE 83 0.0064
185 CARDIAC VENTRICULAR THROMBOSIS 8 0.0062
186 MONOCYTE COUNT INCREASED 22 0.0061
187 SEBORRHOEIC DERMATITIS 10 0.0060
188 THROAT CLEARING 22 0.0059
189 CYTOMEGALOVIRUS VIRAEMIA 26 0.0058
190 VIRAEMIA 8 0.0058
191 PRODUCT PACKAGING CONFUSION 14 0.0058
192 TASTE DISORDER 116 0.0057
193 PERIARTHRITIS 13 0.0057
194 RHEUMATOID FACTOR POSITIVE 33 0.0057
195 APHASIA 171 0.0057
196 ATROPHY 11 0.0056
197 MUSCULOSKELETAL PAIN 295 0.0056
198 GLOSSODYNIA 126 0.0056
199 THERAPEUTIC PRODUCT EFFECT DECREASED 252 0.0056
200 DEMYELINATION 23 0.0056
201 SPINAL DISORDER 53 0.0056
202 CYSTITIS 176 0.0055
203 MUSCULOSKELETAL STIFFNESS 479 0.0055
204 CEREBROSPINAL FLUID LEAKAGE 10 0.0054
205 CONJUNCTIVITIS 100 0.0054
206 TYPE 2 DIABETES MELLITUS 181 0.0054
207 PHOTOPHOBIA 100 0.0053
208 ARTHRITIS 414 0.0053
209 PNEUMATOSIS INTESTINALIS 15 0.0053
210 PSORIATIC ARTHROPATHY 213 0.0052
211 GASTROINTESTINAL TOXICITY 25 0.0052
212 SPONDYLOLISTHESIS 9 0.0052
213 CONGENITAL ANOMALY 40 0.0052
214 JOINT DESTRUCTION 8 0.0051
215 BONE DENSITY DECREASED 160 0.0051
216 IMPAIRED WORK ABILITY 107 0.0050
217 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 41 0.0050
218 OBESITY 79 0.0050
219 CEREBRAL VENOUS THROMBOSIS 9 0.0050
220 SPINAL PAIN 58 0.0049
221 ASPERGILLUS INFECTION 32 0.0049
222 CATARACT 289 0.0048
223 BLOOD URIC ACID INCREASED 28 0.0048
224 DRY EYE 242 0.0048
225 BLOOD PRESSURE SYSTOLIC DECREASED 22 0.0048
226 CHOLECYSTITIS ACUTE 27 0.0048
227 ASTHMA 537 0.0047
228 ADVERSE REACTION 62 0.0047
229 DYSARTHRIA 175 0.0046
230 GAIT INABILITY 154 0.0046
231 APLASIA 9 0.0046
232 HYPERHIDROSIS 590 0.0046
233 SYSTEMIC LUPUS ERYTHEMATOSUS 162 0.0046
234 EPILEPSY 137 0.0045
235 MENINGITIS ASEPTIC 20 0.0045
236 ARTHROPATHY 246 0.0044
237 ORAL FUNGAL INFECTION 12 0.0044
238 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 9 0.0043
239 RASH VESICULAR 21 0.0043
240 IMPAIRED HEALING 142 0.0043
241 MUSCULAR WEAKNESS 490 0.0043
242 FEELING JITTERY 82 0.0043
243 EYE INJURY 13 0.0043
244 KERATITIS 13 0.0043
245 DRUG TOLERANCE DECREASED 12 0.0043
246 VASCULAR OCCLUSION 9 0.0043
247 IRRITABLE BOWEL SYNDROME 90 0.0042
248 NIGHT SWEATS 135 0.0042
249 POLYARTHRITIS 22 0.0042
250 ADENOVIRUS INFECTION 12 0.0041
251 LUMBAR SPINAL STENOSIS 12 0.0041
252 GRAFT VERSUS HOST DISEASE IN SKIN 9 0.0041
253 UNDERWEIGHT 8 0.0041
254 WRONG DRUG ADMINISTERED 36 0.0040
255 SPINAL COLUMN STENOSIS 19 0.0040
256 LUNG DISORDER 196 0.0040
257 WHEEZING 237 0.0040
258 SPINAL OSTEOARTHRITIS 35 0.0040
259 RED BLOOD CELL SEDIMENTATION RATE INCREASED 44 0.0040
260 INJECTION SITE NECROSIS 8 0.0039
261 DIABETIC COMPLICATION 10 0.0039
262 NOCARDIOSIS 10 0.0039
263 HEPATITIS 100 0.0039
264 INFLAMMATION 201 0.0039
265 POST-TRAUMATIC STRESS DISORDER 26 0.0039
266 ADRENAL INSUFFICIENCY 47 0.0039
267 IMPAIRED SELF-CARE 8 0.0039
268 INTENTIONAL PRODUCT MISUSE 338 0.0039
269 MUCORMYCOSIS 10 0.0038
270 FOOT DEFORMITY 42 0.0038
271 PSORIASIS 493 0.0038
272 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 8 0.0038
273 LIVER INJURY 92 0.0037
274 MENISCUS INJURY 23 0.0037
275 EXPOSED BONE IN JAW 8 0.0037
276 OSTEOPENIA 56 0.0037
277 POOR VENOUS ACCESS 38 0.0037
278 DRUG-INDUCED LIVER INJURY 115 0.0037
279 GASTROINTESTINAL DISORDER 325 0.0036
280 HYPERSENSITIVITY 665 0.0036
281 CARPAL TUNNEL SYNDROME 50 0.0036
282 VENOUS THROMBOSIS 14 0.0036
283 RASH PRURITIC 193 0.0036
284 SUPRAVENTRICULAR EXTRASYSTOLES 12 0.0035
285 DRY MOUTH 288 0.0035
286 ENDODONTIC PROCEDURE 9 0.0035
287 DYSLIPIDAEMIA 18 0.0035
288 HERPES SIMPLEX 23 0.0035
289 BLOOD PRESSURE DIASTOLIC DECREASED 26 0.0035
290 ROTATOR CUFF SYNDROME 45 0.0035
291 LICHENOID KERATOSIS 8 0.0035
292 AORTIC ARTERIOSCLEROSIS 9 0.0035
293 NECK PAIN 190 0.0034
294 ANKYLOSING SPONDYLITIS 44 0.0033
295 THROMBOCYTOPENIA 369 0.0033
296 EXOSTOSIS 30 0.0033
297 PRODUCT USE ISSUE 606 0.0032
298 STAPHYLOCOCCAL BACTERAEMIA 14 0.0032
299 URINARY TRACT INFECTION BACTERIAL 8 0.0032
300 EXCORIATION 8 0.0032
301 SWOLLEN JOINT COUNT INCREASED 10 0.0031
302 INTERVERTEBRAL DISC DEGENERATION 29 0.0031
303 FAECAL INCONTINENCE 15 0.0031
304 SINUSITIS 318 0.0031
305 BRONCHOPULMONARY ASPERGILLOSIS 24 0.0031
306 VULVOVAGINAL DRYNESS 10 0.0031
307 LIPOMA 8 0.0031
308 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 20 0.0031
309 RED BLOOD CELL COUNT DECREASED 87 0.0030
310 RADICULOPATHY 8 0.0030
311 OTITIS MEDIA 10 0.0030
312 PEPTIC ULCER 10 0.0030
313 SCIATICA 48 0.0030
314 INJECTION SITE INFLAMMATION 15 0.0030
315 TEMPERATURE INTOLERANCE 31 0.0030
316 SLEEP DISORDER 212 0.0030
317 MIOSIS 24 0.0030
318 BRONCHIECTASIS 20 0.0030
319 POOR QUALITY DRUG ADMINISTERED 19 0.0029
320 HYPERTENSION 621 0.0029
321 LIVER DISORDER 130 0.0029
322 HEPATIC NECROSIS 11 0.0029
323 BLOOD PRESSURE FLUCTUATION 70 0.0029
324 PUSTULAR PSORIASIS 10 0.0029
325 MOBILITY DECREASED 208 0.0029
326 INFECTION 419 0.0029
327 MUSCLE STRAIN 25 0.0029
328 RED CELL DISTRIBUTION WIDTH INCREASED 12 0.0029
329 RHINORRHOEA 186 0.0029
330 PERIPHERAL SWELLING 443 0.0029
331 BLOOD CHOLESTEROL INCREASED 134 0.0029
332 BACK PAIN 663 0.0029
333 HAEMOGLOBIN INCREASED 13 0.0028
334 TYPE I HYPERSENSITIVITY 10 0.0028
335 LIVER FUNCTION TEST INCREASED 61 0.0028
336 DEPRESSIVE SYMPTOM 10 0.0028
337 NEUTROPHIL COUNT INCREASED 29 0.0028
338 SKIN ULCER 73 0.0028
339 ULCER HAEMORRHAGE 19 0.0028
340 DENTAL CARIES 31 0.0028
341 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 48 0.0028
342 LOOSE TOOTH 9 0.0028
343 LOWER RESPIRATORY TRACT INFECTION 127 0.0028
344 SWELLING 261 0.0028
345 MONOPLEGIA 12 0.0028
346 QUALITY OF LIFE DECREASED 37 0.0028
347 JOINT STIFFNESS 72 0.0027
348 ACTINIC KERATOSIS 7 0.0027
349 DYSPHAGIA 256 0.0027
350 TRIGGER FINGER 11 0.0027
351 LEUKOENCEPHALOPATHY 10 0.0027
352 ERYTHEMA 551 0.0027
353 INFUSION SITE REACTION 8 0.0027
354 RETCHING 57 0.0027
355 PAIN 1628 0.0026
356 ECONOMIC PROBLEM 40 0.0026
357 URINE ABNORMALITY 12 0.0026
358 INTERSTITIAL LUNG DISEASE 127 0.0026
359 VENTRICULAR EXTRASYSTOLES 27 0.0026
360 RALES 15 0.0026
361 INJURY 181 0.0026
362 HAEMOLYTIC ANAEMIA 23 0.0026
363 NERVE INJURY 28 0.0025
364 PARALYSIS 36 0.0025
365 BACTERIAL SEPSIS 8 0.0025
366 PULMONARY FIBROSIS 47 0.0024
367 PSEUDOMONAS INFECTION 21 0.0024
368 HYPERLIPIDAEMIA 29 0.0024
369 CHEST DISCOMFORT 248 0.0024
370 TENDON INJURY 9 0.0024
371 DERMATITIS EXFOLIATIVE 12 0.0024
372 STAPHYLOCOCCAL INFECTION 79 0.0024
373 DIVERTICULUM 17 0.0024
374 CHOLECYSTITIS CHRONIC 16 0.0024
375 ROSACEA 11 0.0024
376 INCORRECT ROUTE OF DRUG ADMINISTRATION 84 0.0023
377 INTERVERTEBRAL DISC DISORDER 10 0.0023
378 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 112 0.0023
379 TRISMUS 12 0.0023
380 PALPITATIONS 272 0.0023
381 OSTEOMYELITIS 42 0.0023
382 ABSCESS 37 0.0023
383 ANAPHYLACTIC REACTION 128 0.0023
384 FUNCTIONAL GASTROINTESTINAL DISORDER 8 0.0023
385 RHINOVIRUS INFECTION 9 0.0023
386 INTENTIONAL PRODUCT USE ISSUE 202 0.0023
387 TENDON DISORDER 15 0.0023
388 BLISTER 129 0.0023
389 DIVERTICULUM INTESTINAL 10 0.0023
390 LEUKOPENIA 114 0.0023
391 NECROTISING FASCIITIS 8 0.0023
392 CEREBRAL ATROPHY 9 0.0023
393 AUTOIMMUNE DISORDER 22 0.0023
394 GRAFT VERSUS HOST DISEASE 16 0.0022
395 MULTIPLE INJURIES 14 0.0022
396 BLOOD PRESSURE INCREASED 339 0.0022
397 INFLUENZA LIKE ILLNESS 182 0.0022
398 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 157 0.0022
399 LIVER FUNCTION TEST ABNORMAL 64 0.0022
400 GLUCOSE TOLERANCE IMPAIRED 13 0.0022
401 POST PROCEDURAL COMPLICATION 42 0.0022
402 GASTROOESOPHAGEAL REFLUX DISEASE 176 0.0022
403 PROCTALGIA 14 0.0022
404 DISABILITY 43 0.0022
405 SKIN EXFOLIATION 183 0.0022
406 RENAL FUNCTION TEST ABNORMAL 10 0.0022
407 PYREXIA 736 0.0021
408 WALKING AID USER 14 0.0021
409 PERIORBITAL SWELLING 12 0.0021
410 AORTIC VALVE INCOMPETENCE 9 0.0021
411 MATERNAL EXPOSURE DURING PREGNANCY 188 0.0021
412 MALABSORPTION 11 0.0021
413 TENDON RUPTURE 26 0.0021
414 CONFUSIONAL STATE 338 0.0021
415 MIGRAINE 198 0.0021
416 BLOOD TEST ABNORMAL 29 0.0021
417 CARBOHYDRATE ANTIGEN 125 INCREASED 7 0.0021
418 PARONYCHIA 9 0.0020
419 ECCHYMOSIS 14 0.0020
420 CONSTIPATION 445 0.0020
421 ILL-DEFINED DISORDER 123 0.0020
422 WHEELCHAIR USER 9 0.0020
423 HEPATOTOXICITY 45 0.0020
424 DISCOMFORT 123 0.0020
425 JOINT INJURY 43 0.0020
426 BLOOD PRESSURE ABNORMAL 40 0.0020
427 EAR PAIN 39 0.0020
428 OCULAR HYPERAEMIA 95 0.0020
429 BONE DISORDER 36 0.0020
430 PULMONARY MASS 29 0.0019
431 PAIN IN EXTREMITY 573 0.0019
432 OVERDOSE 419 0.0019
433 ANAPHYLACTIC SHOCK 50 0.0019
434 TENDONITIS 30 0.0019
435 SCOLIOSIS 12 0.0019
436 STOMATITIS 117 0.0019
437 LIGAMENT SPRAIN 19 0.0019
438 INFLUENZA 214 0.0019
439 EYE PAIN 107 0.0019
440 ARTHRALGIA 780 0.0019
441 ENTERITIS 12 0.0019
442 COMPRESSION FRACTURE 10 0.0019
443 DIABETES MELLITUS INADEQUATE CONTROL 33 0.0019
444 HYPERBILIRUBINAEMIA 19 0.0018
445 THROAT IRRITATION 82 0.0018
446 MUSCLE ATROPHY 23 0.0018
447 GENERAL PHYSICAL HEALTH DETERIORATION 210 0.0018
448 TOOTH FRACTURE 20 0.0018
449 HEADACHE 1137 0.0018
450 FUNGAL INFECTION 60 0.0018
451 WHITE BLOOD CELL COUNT INCREASED 69 0.0018
452 IRON DEFICIENCY 8 0.0018
453 WRONG PRODUCT ADMINISTERED 12 0.0018
454 COLITIS 67 0.0018
455 RASH 766 0.0018
456 CARDIOMEGALY 21 0.0017
457 SWELLING FACE 111 0.0017
458 OSTEOPOROSIS 70 0.0017
459 CLOSTRIDIUM DIFFICILE COLITIS 18 0.0017
460 SARCOIDOSIS 8 0.0017
461 PULSE ABSENT 8 0.0017
462 MUCOSAL INFLAMMATION 44 0.0017
463 MITRAL VALVE INCOMPETENCE 19 0.0017
464 KNEE ARTHROPLASTY 35 0.0017
465 HYPOAESTHESIA 248 0.0017
466 LUPUS-LIKE SYNDROME 15 0.0017
467 OPTIC NEURITIS 15 0.0016
468 JAW DISORDER 9 0.0016
469 RESPIRATORY DISORDER 49 0.0016
470 NASOPHARYNGITIS 300 0.0016
471 CELLULITIS 82 0.0016
472 BONE MARROW FAILURE 33 0.0016
473 STREPTOCOCCAL INFECTION 9 0.0016
474 OSTEONECROSIS 53 0.0016
475 BLOOD ALKALINE PHOSPHATASE INCREASED 40 0.0016
476 BACTERIAL INFECTION 30 0.0016
477 CORONARY ARTERY OCCLUSION 22 0.0016
478 THERAPY NON-RESPONDER 72 0.0016
479 ENCEPHALITIS 11 0.0016
480 DYSPEPSIA 156 0.0016
481 DRUG TOLERANCE 8 0.0016
482 WEIGHT INCREASED 354 0.0016
483 DEFAECATION URGENCY 11 0.0016
484 FACIAL PAIN 14 0.0016
485 FATIGUE 1220 0.0016
486 CONDITION AGGRAVATED 475 0.0016
487 SENSORY DISTURBANCE 25 0.0016
488 HEPATIC STEATOSIS 29 0.0016
489 PNEUMONIA 504 0.0016
490 PERIPHERAL VASCULAR DISORDER 8 0.0016
491 UVEITIS 21 0.0015
492 MALAISE 678 0.0015
493 HIATUS HERNIA 20 0.0015
494 WEIGHT FLUCTUATION 16 0.0015
495 OFF LABEL USE 1337 0.0015
496 DERMATITIS BULLOUS 11 0.0015
497 PARAESTHESIA 239 0.0015
498 PHOTOSENSITIVITY REACTION 25 0.0015
499 BLOOD ALBUMIN DECREASED 12 0.0015
500 MYOCLONUS 18 0.0015
501 LIQUID PRODUCT PHYSICAL ISSUE 11 0.0015
502 CONTUSION 145 0.0015
503 BLOOD UREA INCREASED 25 0.0015
504 HEPATIC CYTOLYSIS 19 0.0015
505 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 11 0.0015
506 ABDOMINAL DISTENSION 153 0.0015
507 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
508 HYPERAESTHESIA 12 0.0015
509 IMPAIRED QUALITY OF LIFE 21 0.0015
510 EYE IRRITATION 83 0.0014
511 INJECTION SITE REACTION 99 0.0014
512 HYPERTRANSAMINASAEMIA 10 0.0014
513 PRODUCT QUALITY ISSUE 194 0.0014
514 CONCUSSION 11 0.0014
515 ANXIETY 403 0.0014
516 ABDOMINAL TENDERNESS 7 0.0014
517 NEURALGIA 34 0.0014
518 VISUAL DISTURBANCE 8 0.0014
519 SKIN ATROPHY 8 0.0014
520 FALL 461 0.0014
521 HYPERTRIGLYCERIDAEMIA 8 0.0014
522 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
523 SEPTIC SHOCK 59 0.0014
524 LOWER LIMB FRACTURE 26 0.0014
525 MYALGIA 230 0.0014
526 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 74 0.0013
527 COUGH 377 0.0013
528 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
529 ODYNOPHAGIA 8 0.0013
530 HICCUPS 11 0.0013
531 POLYNEUROPATHY 16 0.0013
532 THYROID CANCER 16 0.0013
533 ABDOMINAL DISCOMFORT 221 0.0013
534 URINARY INCONTINENCE 39 0.0013
535 ACTIVITIES OF DAILY LIVING IMPAIRED 26 0.0013
536 BRONCHITIS 97 0.0013
537 NEOPLASM MALIGNANT 87 0.0013
538 RENAL FAILURE CHRONIC 10 0.0013
539 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 22 0.0013
540 PHARYNGITIS 16 0.0013
541 APHTHOUS ULCER 10 0.0013
542 GASTRIC DISORDER 44 0.0013
543 PRE-EXISTING CONDITION IMPROVED 8 0.0013
544 INTERVERTEBRAL DISC PROTRUSION 28 0.0013
545 DRY THROAT 13 0.0013
546 LACERATION 12 0.0013
547 ARTERIOSCLEROSIS 12 0.0013
548 VISUAL IMPAIRMENT 158 0.0013
549 LYMPHOPENIA 18 0.0013
550 RIB FRACTURE 26 0.0013
551 CYTOMEGALOVIRUS INFECTION 21 0.0013
552 PROCEDURAL PAIN 35 0.0013
553 LIMB DISCOMFORT 39 0.0013
554 GASTRITIS 33 0.0013
555 GROIN PAIN 11 0.0013
556 LUNG INFILTRATION 11 0.0012
557 LYMPHADENOPATHY 44 0.0012
558 MUSCLE SPASMS 227 0.0012
559 MUSCLE DISORDER 10 0.0012
560 ANGINA UNSTABLE 8 0.0012
561 HAEMORRHOIDS 24 0.0012
562 MUSCULOSKELETAL CHEST PAIN 19 0.0012
563 SCAR 21 0.0012
564 ASTHENIA 460 0.0012
565 CEREBROVASCULAR ACCIDENT 207 0.0012
566 POLYP 8 0.0012
567 HEPATOMEGALY 12 0.0012
568 BODY TEMPERATURE DECREASED 12 0.0012
569 DEPRESSION 277 0.0012
570 TOOTH INFECTION 16 0.0012
571 URTICARIA 203 0.0012
572 BLADDER DISORDER 12 0.0012
573 THROMBOSIS 97 0.0012
574 MEDICATION ERROR 67 0.0012
575 HAEMATOCHEZIA 66 0.0012
576 ROAD TRAFFIC ACCIDENT 50 0.0012
577 PRESYNCOPE 29 0.0012
578 NEUROPATHY PERIPHERAL 113 0.0012
579 ASPIRATION 13 0.0012
580 BLOOD PRESSURE SYSTOLIC INCREASED 23 0.0012
581 HYPONATRAEMIA 66 0.0012
582 MATERNAL EXPOSURE BEFORE PREGNANCY 8 0.0012
583 HYPOKALAEMIA 54 0.0012
584 PAIN IN JAW 33 0.0012
585 HYSTERECTOMY 10 0.0012
586 FAECES DISCOLOURED 25 0.0012
587 PLATELET COUNT INCREASED 15 0.0011
588 IMMUNE SYSTEM DISORDER 15 0.0011
589 SINUS BRADYCARDIA 11 0.0011
590 JOINT DISLOCATION 12 0.0011
591 WHITE BLOOD CELL COUNT DECREASED 123 0.0011
592 IMMUNOSUPPRESSION 10 0.0011
593 ABASIA 28 0.0011
594 TRICUSPID VALVE INCOMPETENCE 9 0.0011
595 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
596 ATRIAL FLUTTER 9 0.0011
597 HYPOTHYROIDISM 36 0.0011
598 DIZZINESS 559 0.0011
599 PRODUCT SUPPLY ISSUE 8 0.0011
600 KNEE OPERATION 11 0.0011
601 HEPATIC CIRRHOSIS 21 0.0011
602 MYOSITIS 10 0.0011
603 COGNITIVE DISORDER 52 0.0011
604 HAEMOGLOBIN DECREASED 114 0.0011
605 HIP ARTHROPLASTY 17 0.0011
606 MUSCULOSKELETAL DISCOMFORT 19 0.0011
607 ENCEPHALOPATHY 27 0.0011
608 PNEUMOCYSTIS JIROVECII PNEUMONIA 11 0.0011
609 EMPHYSEMA 11 0.0011
610 PNEUMONIA BACTERIAL 10 0.0011
611 GLYCOSYLATED HAEMOGLOBIN INCREASED 27 0.0011
612 RESPIRATORY FAILURE 78 0.0011
613 HYDRONEPHROSIS 8 0.0011
614 INCORRECT PRODUCT ADMINISTRATION DURATION 23 0.0011
615 ILLNESS 109 0.0011
616 MYOCARDIAL ISCHAEMIA 12 0.0011
617 EAR INFECTION 28 0.0011
618 VIRAL INFECTION 35 0.0011
619 MUSCULOSKELETAL DISORDER 20 0.0010
620 SLEEP APNOEA SYNDROME 20 0.0010
621 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
622 NAUSEA 824 0.0010
623 PRODUCT USE IN UNAPPROVED INDICATION 253 0.0010
624 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
625 DRUG INEFFECTIVE 1334 0.0010
626 FEELING ABNORMAL 242 0.0010
627 TRANSIENT ISCHAEMIC ATTACK 34 0.0010
628 ABDOMINAL PAIN UPPER 207 0.0010
629 GOUT 18 0.0010
630 RECTAL HAEMORRHAGE 43 0.0010
631 SKIN REACTION 14 0.0010
632 SYNCOPE 99 0.0010
633 SINUS TACHYCARDIA 14 0.0010
634 EYELID PTOSIS 10 0.0010
635 RESPIRATORY DISTRESS 27 0.0010
636 CHOLELITHIASIS 32 0.0010
637 POOR QUALITY SLEEP 21 0.0010
638 NERVE COMPRESSION 9 0.0010
639 GRAND MAL CONVULSION 9 0.0010
640 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
641 LYMPHOMA 15 0.0010
642 IMPAIRED DRIVING ABILITY 11 0.0010
643 NEPHROPATHY 9 0.0010
644 BREAST CANCER STAGE II 8 0.0010
645 LIP SWELLING 32 0.0010
646 SEPSIS 107 0.0010
647 VERTIGO 58 0.0010
648 BRAIN OEDEMA 12 0.0009
649 GASTRIC ULCER 18 0.0009
650 PNEUMOTHORAX 15 0.0009
651 TOOTH DISORDER 21 0.0009
652 VITAMIN D DECREASED 8 0.0009
653 ABDOMINAL PAIN 216 0.0009
654 MYOPATHY 8 0.0009
655 VOMITING 434 0.0009
656 ORAL HERPES 18 0.0009
657 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
658 NASAL CONGESTION 54 0.0009
659 BEDRIDDEN 12 0.0009
660 VENTRICULAR TACHYCARDIA 15 0.0009
661 OXYGEN SATURATION DECREASED 51 0.0009
662 NOCTURIA 11 0.0009
663 MEMORY IMPAIRMENT 124 0.0009
664 OVARIAN CYST 9 0.0009
665 HYPOKINESIA 13 0.0009
666 SPINAL OPERATION 11 0.0009
667 SKIN INFECTION 10 0.0009
668 ATRIAL FIBRILLATION 86 0.0009
669 PNEUMONITIS 24 0.0009
670 PSYCHOTIC DISORDER 26 0.0009
671 EAR DISCOMFORT 9 0.0009
672 INSOMNIA 232 0.0009
673 DEPRESSED MOOD 46 0.0009
674 DYSURIA 32 0.0009
675 MUSCLE TWITCHING 20 0.0009
676 PERSONALITY CHANGE 8 0.0009
677 MASS 12 0.0009
678 SEXUAL DYSFUNCTION 10 0.0009
679 HALLUCINATION, VISUAL 18 0.0009
680 SUDDEN DEATH 9 0.0008
681 HEART RATE INCREASED 84 0.0008
682 HEPATOCELLULAR INJURY 12 0.0008
683 DEVICE RELATED INFECTION 13 0.0008
684 DYSPNOEA 477 0.0008
685 BACTERAEMIA 10 0.0008
686 MOVEMENT DISORDER 27 0.0008
687 WRIST FRACTURE 10 0.0008
688 BLOOD GLUCOSE DECREASED 40 0.0008
689 DEEP VEIN THROMBOSIS 54 0.0008
690 GAIT DISTURBANCE 159 0.0008
691 LEUKOCYTOSIS 15 0.0008
692 BURNING SENSATION 58 0.0008
693 SHOCK 19 0.0008
694 RESTLESS LEGS SYNDROME 15 0.0008
695 OESOPHAGITIS 9 0.0008
696 DYSSTASIA 24 0.0008
697 HALLUCINATION, AUDITORY 13 0.0008
698 CYTOPENIA 10 0.0008
699 OEDEMA PERIPHERAL 99 0.0008
700 RASH GENERALISED 21 0.0008
701 MOUTH ULCERATION 17 0.0008
702 LOCAL SWELLING 14 0.0008
703 NERVOUS SYSTEM DISORDER 25 0.0008
704 OROPHARYNGEAL PAIN 74 0.0008
705 BALANCE DISORDER 69 0.0008
706 ALANINE AMINOTRANSFERASE INCREASED 49 0.0008
707 DIARRHOEA 515 0.0008
708 HEART RATE DECREASED 28 0.0008
709 DERMATITIS ALLERGIC 10 0.0008
710 CHEST PAIN 147 0.0008
711 WEIGHT DECREASED 221 0.0008
712 PLEURAL EFFUSION 48 0.0008
713 SEASONAL ALLERGY 11 0.0008
714 THERAPEUTIC RESPONSE DECREASED 47 0.0008
715 TOOTHACHE 14 0.0008
716 LUNG INFECTION 12 0.0008
717 PALLOR 21 0.0008
718 DYSPNOEA EXERTIONAL 29 0.0008
719 SPLENOMEGALY 9 0.0008
720 PULMONARY EMBOLISM 73 0.0008
721 OSTEONECROSIS OF JAW 19 0.0008
722 HERPES ZOSTER 44 0.0008
723 ALOPECIA 150 0.0008
724 ANHEDONIA 20 0.0008
725 BLOOD IRON DECREASED 9 0.0008
726 MENTAL STATUS CHANGES 21 0.0008
727 UPPER LIMB FRACTURE 15 0.0008
728 HEART RATE IRREGULAR 17 0.0008
729 ANGIOEDEMA 33 0.0007
730 PRODUCT ADMINISTRATION ERROR 15 0.0007
731 MULTIPLE ORGAN DYSFUNCTION SYNDROME 21 0.0007
732 PRURITUS GENERALISED 16 0.0007
733 COLD SWEAT 13 0.0007
734 BIPOLAR DISORDER 8 0.0007
735 CYST 9 0.0007
736 THERAPEUTIC RESPONSE SHORTENED 24 0.0007
737 PRURITUS 278 0.0007
738 DIABETES MELLITUS 55 0.0007
739 TACHYCARDIA 64 0.0007
740 INJECTION SITE DISCOLOURATION 9 0.0007
741 PULMONARY HYPERTENSION 15 0.0007
742 OEDEMA 39 0.0007
743 PANCREATITIS 38 0.0007
744 MALNUTRITION 8 0.0007
745 PHARYNGEAL OEDEMA 11 0.0007
746 FACE OEDEMA 12 0.0007
747 CANDIDA INFECTION 12 0.0007
748 JAUNDICE 19 0.0007
749 BLOOD CREATININE INCREASED 46 0.0007
750 DERMATITIS CONTACT 8 0.0007
751 BRONCHOSPASM 10 0.0007
752 AGRANULOCYTOSIS 13 0.0007
753 DIPLOPIA 18 0.0007
754 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36 0.0007
755 VASCULITIS 8 0.0007
756 FOOT FRACTURE 13 0.0007
757 AMENORRHOEA 12 0.0007
758 DRUG ADMINISTRATION ERROR 21 0.0007
759 MUSCLE TIGHTNESS 11 0.0007
760 COVID-19 PNEUMONIA 8 0.0007
761 HYPOTENSION 135 0.0007
762 MANIA 11 0.0007
763 LOCALISED INFECTION 16 0.0007
764 CORONARY ARTERY DISEASE 20 0.0007
765 NO THERAPEUTIC RESPONSE 8 0.0007
766 RESTLESSNESS 24 0.0007
767 PERIPHERAL COLDNESS 9 0.0007
768 NEPHROLITHIASIS 30 0.0007
769 RESPIRATORY TRACT INFECTION 17 0.0007
770 PRESCRIBED UNDERDOSE 13 0.0007
771 MULTIPLE SCLEROSIS 31 0.0006
772 ANKLE FRACTURE 10 0.0006
773 TOOTH EXTRACTION 8 0.0006
774 BASAL CELL CARCINOMA 10 0.0006
775 BLOOD GLUCOSE FLUCTUATION 7 0.0006
776 TINNITUS 29 0.0006
777 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
778 INJECTION SITE IRRITATION 8 0.0006
779 ACUTE RESPIRATORY FAILURE 12 0.0006
780 MOOD ALTERED 17 0.0006
781 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
782 HYPERTHYROIDISM 9 0.0006
783 RESPIRATORY ARREST 17 0.0006
784 UNDERDOSE 45 0.0006
785 AMNESIA 40 0.0006
786 RENAL FAILURE ACUTE 26 0.0006
787 CARDIOMYOPATHY 9 0.0006
788 ADVERSE EVENT 56 0.0006
789 HAEMATOCRIT DECREASED 12 0.0006
790 DELIRIUM 21 0.0006
791 URINARY TRACT INFECTION 103 0.0006
792 PNEUMONIA ASPIRATION 15 0.0006
793 URINARY RETENTION 20 0.0006
794 PREGNANCY 12 0.0006
795 DECREASED APPETITE 138 0.0006
796 THROAT TIGHTNESS 16 0.0006
797 PANCYTOPENIA 33 0.0006
798 FLUSHING 60 0.0006
799 LIMB INJURY 16 0.0006
800 DRUG DISPENSING ERROR 9 0.0006
801 TACHYPNOEA 8 0.0006
802 BLOOD PRESSURE DECREASED 39 0.0006
803 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
804 UNRESPONSIVE TO STIMULI 15 0.0006
805 PARANOIA 10 0.0006
806 ADVERSE DRUG REACTION 52 0.0006
807 ACUTE MYOCARDIAL INFARCTION 17 0.0006
808 INJECTION SITE SWELLING 44 0.0006
809 CARDIAC FAILURE 46 0.0006
810 CEREBRAL INFARCTION 14 0.0006
811 FEELING HOT 35 0.0006
812 ARRHYTHMIA 27 0.0006
813 HERNIA 11 0.0006
814 SKIN DISCOLOURATION 26 0.0006
815 BRADYCARDIA 30 0.0006
816 GALLBLADDER DISORDER 10 0.0006
817 CARDIAC ARREST 46 0.0006
818 DISTURBANCE IN ATTENTION 30 0.0006
819 PARAESTHESIA ORAL 8 0.0006
820 ABDOMINAL PAIN LOWER 14 0.0006
821 NIGHTMARE 19 0.0005
822 APATHY 8 0.0005
823 MELAENA 12 0.0005
824 PRODUCTIVE COUGH 26 0.0005
825 SWOLLEN TONGUE 17 0.0005
826 HAEMATOMA 14 0.0005
827 LOSS OF CONSCIOUSNESS 69 0.0005
828 PULMONARY OEDEMA 24 0.0005
829 HYPOAESTHESIA ORAL 8 0.0005
830 CIRCULATORY COLLAPSE 9 0.0005
831 BLOOD URINE PRESENT 10 0.0005
832 DRUG EFFECT INCOMPLETE 19 0.0005
833 PANIC ATTACK 19 0.0005
834 CHOLESTASIS 10 0.0005
835 FEAR 14 0.0005
836 THYROID DISORDER 8 0.0005
837 FOETAL EXPOSURE DURING PREGNANCY 42 0.0005
838 PLATELET COUNT DECREASED 55 0.0005
839 HAEMATEMESIS 13 0.0005
840 FEBRILE NEUTROPENIA 34 0.0005
841 VISION BLURRED 70 0.0005
842 DRUG RESISTANCE 13 0.0005
843 MENTAL DISORDER 22 0.0005
844 DIVERTICULITIS 14 0.0005
845 PREMATURE BABY 15 0.0005
846 TARDIVE DYSKINESIA 14 0.0005
847 TREATMENT NONCOMPLIANCE 27 0.0005
848 BACK DISORDER 8 0.0005
849 ORAL PAIN 11 0.0005
850 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
851 BLINDNESS 20 0.0005
852 BODY TEMPERATURE INCREASED 10 0.0005
853 DRUG EFFECT DECREASED 26 0.0005
854 TOOTH LOSS 10 0.0005
855 MIDDLE INSOMNIA 9 0.0005
856 SKIN DISORDER 16 0.0005
857 AGGRESSION 24 0.0005
858 NERVOUSNESS 25 0.0005
859 TREMOR 78 0.0005
860 RENAL FAILURE 62 0.0005
861 HYPERGLYCAEMIA 17 0.0005
862 ERUCTATION 9 0.0005
863 COVID-19 81 0.0005
864 CHILLS 54 0.0005
865 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 83 0.0005
866 ORTHOSTATIC HYPOTENSION 8 0.0005
867 PRODUCT DOSE OMISSION IN ERROR 13 0.0005
868 ANAEMIA 87 0.0005
869 EMOTIONAL DISORDER 14 0.0005
870 DRUG ERUPTION 8 0.0005
871 STEVENS-JOHNSON SYNDROME 10 0.0004
872 ANGER 15 0.0004
873 DYSKINESIA 18 0.0004
874 RENAL INJURY 13 0.0004
875 SKIN LESION 12 0.0004
876 PRODUCT COMPLAINT 11 0.0004
877 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
878 FEELING COLD 12 0.0004
879 DEMENTIA 12 0.0004
880 RASH MACULAR 15 0.0004
881 EMOTIONAL DISTRESS 51 0.0004
882 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
883 HYPOGLYCAEMIA 20 0.0004
884 DYSPHONIA 24 0.0004
885 HAEMATURIA 14 0.0004
886 AGITATION 30 0.0004
887 DISORIENTATION 16 0.0004
888 SPEECH DISORDER 21 0.0004
889 PANCREATITIS ACUTE 9 0.0004
890 HYPOXIA 14 0.0004
891 LACRIMATION INCREASED 12 0.0004
892 UNEVALUABLE EVENT 30 0.0004
893 CARDIAC DISORDER 37 0.0004
894 HYPOPHAGIA 10 0.0004
895 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
896 CARDIAC FAILURE CONGESTIVE 31 0.0004
897 HEPATIC FUNCTION ABNORMAL 14 0.0004
898 INJECTION SITE PAIN 115 0.0004
899 HOT FLUSH 28 0.0004
900 BLOOD GLUCOSE INCREASED 70 0.0004
901 SUICIDAL IDEATION 34 0.0004
902 BLOOD POTASSIUM DECREASED 11 0.0004
903 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
904 VISUAL ACUITY REDUCED 12 0.0004
905 EPISTAXIS 27 0.0004
906 POLLAKIURIA 15 0.0004
907 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
908 SURGERY 21 0.0004
909 CRYING 13 0.0004
910 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
911 CHRONIC KIDNEY DISEASE 27 0.0004
912 FEMUR FRACTURE 11 0.0004
913 ERECTILE DYSFUNCTION 9 0.0004
914 PERICARDIAL EFFUSION 8 0.0003
915 DEAFNESS 9 0.0003
916 HIP FRACTURE 11 0.0003
917 PRODUCT PRESCRIBING ERROR 8 0.0003
918 FLATULENCE 19 0.0003
919 HAEMORRHAGE 35 0.0003
920 HOSPITALISATION 51 0.0003
921 LETHARGY 19 0.0003
922 HYPOACUSIS 14 0.0003
923 EXTRAPYRAMIDAL DISORDER 8 0.0003
924 ACUTE KIDNEY INJURY 49 0.0003
925 HALLUCINATION 24 0.0003
926 DISEASE RECURRENCE 15 0.0003
927 HYPERSOMNIA 9 0.0003
928 MOOD SWINGS 10 0.0003
929 WITHDRAWAL SYNDROME 13 0.0003
930 MYOCARDIAL INFARCTION 54 0.0003
931 RENAL IMPAIRMENT 26 0.0003
932 BONE PAIN 18 0.0003
933 CEREBRAL HAEMORRHAGE 11 0.0003
934 EYE DISORDER 10 0.0003
935 ABNORMAL BEHAVIOUR 12 0.0003
936 DEHYDRATION 40 0.0003
937 INJECTION SITE ERYTHEMA 37 0.0003
938 CONVULSION 17 0.0003
939 BLOOD BILIRUBIN INCREASED 8 0.0003
940 INJECTION SITE RASH 9 0.0003
941 INTESTINAL OBSTRUCTION 11 0.0003
942 COLITIS ULCERATIVE 13 0.0003
943 SOMNOLENCE 58 0.0003
944 HAEMOPTYSIS 8 0.0003
945 DRUG INTERACTION 45 0.0003
946 INJECTION SITE PRURITUS 19 0.0003
947 CARDIOVASCULAR DISORDER 7 0.0003
948 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
949 ACCIDENTAL OVERDOSE 10 0.0003
950 EYE SWELLING 10 0.0003
951 ECZEMA 14 0.0003
952 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
953 IRRITABILITY 16 0.0003
954 CARDIO-RESPIRATORY ARREST 11 0.0003
955 COMA 12 0.0003
956 SEIZURE 29 0.0003
957 INCORRECT DOSE ADMINISTERED 57 0.0002
958 EXPIRED PRODUCT ADMINISTERED 8 0.0002
959 ASCITES 7 0.0002
960 EYE PRURITUS 8 0.0002
961 THERAPY INTERRUPTED 17 0.0002
962 RENAL DISORDER 11 0.0002
963 NEOPLASM PROGRESSION 8 0.0002
964 NEUTROPENIA 31 0.0002
965 LUNG NEOPLASM MALIGNANT 9 0.0002
966 TOXICITY TO VARIOUS AGENTS 36 0.0002
967 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
968 DYSGEUSIA 15 0.0002
969 PRODUCT DOSE OMISSION ISSUE 58 0.0002
970 RHABDOMYOLYSIS 8 0.0002
971 DISEASE PROGRESSION 21 0.0002
972 INJECTION SITE BRUISING 14 0.0002
973 ACNE 13 0.0002
974 NO ADVERSE EVENT 30 0.0002
975 SUICIDE ATTEMPT 10 0.0002
976 DRY SKIN 22 0.0002
977 DRUG ABUSE 12 0.0001
978 DEATH 123 0.0001
979 PROSTATE CANCER 11 0.0001
980 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
982 SKIN BURNING SENSATION 8 0.0001
983 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21 0.0001
984 INJECTION SITE HAEMORRHAGE 8 0.0001
985 BREAST CANCER 9 0.0001
986 DRUG DEPENDENCE 15 0.0001
987 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
988 DRUG DOSE OMISSION 12 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001